140 related articles for article (PubMed ID: 15233228)
41. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy targeted to cancers through tumoral hormone receptors.
Schally AV; Nagy A
Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601
[TBL] [Abstract][Full Text] [Related]
43. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
[TBL] [Abstract][Full Text] [Related]
44. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
45. Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment.
Salmon RJ; Alran S; Malka I; de Cremoux P; Rosty C; Languille O; Campana F; ; Sigal-Zafrani B
Am J Clin Oncol; 2006 Aug; 29(4):385-8. PubMed ID: 16891867
[TBL] [Abstract][Full Text] [Related]
46. Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.
Prasad V; Fetscher S; Baum RP
J Pharm Pharm Sci; 2007; 10(2):321s-337s. PubMed ID: 17718935
[No Abstract] [Full Text] [Related]
47. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Grozinsky-Glasberg S; Grossman AB; Korbonits M
Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
[TBL] [Abstract][Full Text] [Related]
48. Management of functioning endocrine pancreatic tumors.
Falconi M; Bettini R; Butturini G; Cavallini A; Pederzoli P
J Endocrinol Invest; 2003; 26(8 Suppl):75-8. PubMed ID: 15233218
[No Abstract] [Full Text] [Related]
49. [Anti-hormone breast cancer treatment. Convincing trials do exist--we have to take up a stand now!].
Holmberg SB
Lakartidningen; 2005 Oct 10-16; 102(41):2920-1. PubMed ID: 16294508
[No Abstract] [Full Text] [Related]
50. Octreotide and hepatocellular carcinoma.
Farinati F; Sergio A; Baldan A; Zucchetta P; Corleto VD
Br J Cancer; 2007 Jun; 96(11):1778-9. PubMed ID: 17505506
[No Abstract] [Full Text] [Related]
51. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
52. Resistance to endocrine therapy in breast cancer.
Kurebayashi J
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():39-46. PubMed ID: 16273353
[TBL] [Abstract][Full Text] [Related]
53. Molecular assays to predict prognosis of breast cancer.
Paik S
Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
[No Abstract] [Full Text] [Related]
54. Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue.
De Leo V; La Marca A; Vegni V; Raggi CC; Maggi M; Petraglia F
Fertil Steril; 2003 Oct; 80(4):1058-9. PubMed ID: 14556835
[No Abstract] [Full Text] [Related]
55. Multiple actions of somatostatin in neoplastic disease.
Reubi JC; Laissue JA
Trends Pharmacol Sci; 1995 Mar; 16(3):110-5. PubMed ID: 7792931
[TBL] [Abstract][Full Text] [Related]
56. Pasireoride (Signifor) for Cushing's disease.
Med Lett Drugs Ther; 2013 May; 55(1416):39-40. PubMed ID: 23669783
[No Abstract] [Full Text] [Related]
57. Somatostatin and somatostatin analogues in human breast carcinoma.
Prévost G; Israel L
Recent Results Cancer Res; 1993; 129():63-70. PubMed ID: 8102489
[No Abstract] [Full Text] [Related]
58. Advances in understanding neuronal somatostatin receptors.
Selmer I; Schindler M; Allen JP; Humphrey PP; Emson PC
Regul Pept; 2000 Jun; 90(1-3):1-18. PubMed ID: 10828487
[TBL] [Abstract][Full Text] [Related]
59. [Somatostatin].
Nagasaka Y; Kaneko T
Nihon Rinsho; 1997 Oct; 55 Suppl():142-8. PubMed ID: 9392103
[No Abstract] [Full Text] [Related]
60. Scintigraphy predicts success of hormone therapy.
Gould P
Lancet Oncol; 2006 Mar; 7(3):202. PubMed ID: 16538787
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
